Guo-Liang Huang Selected Research

cis-trans-Isomerases

10/2013	Prolyl isomerase Pin1 regulated signaling pathway revealed by Pin1 +/+ and Pin1 -/- mouse embryonic fibroblast cells.
5/2013	Association between PIN1 promoter polymorphisms and risk of nasopharyngeal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Liang Huang Research Topics

Disease

16	Neoplasms (Cancer) 10/2023 - 04/2010
6	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 01/2012
6	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2012
6	Nasopharyngeal Carcinoma 01/2019 - 01/2011
5	Carcinogenesis 01/2024 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 02/2018 - 01/2012
2	Colitis 10/2015 - 01/2015
2	Graves Disease (Basedow Disease) 01/2013 - 08/2002
1	Virus Diseases (Viral Diseases) 01/2024
1	Infections 01/2024
1	Liver Neoplasms (Liver Cancer) 10/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	COVID-19 10/2020
1	Starvation 02/2018
1	Lung Neoplasms (Lung Cancer) 04/2017
1	Prescription Drug Misuse 01/2017
1	Weight Loss (Weight Reduction) 10/2015
1	Ulcerative Colitis 10/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2015
1	Cholangiocarcinoma 02/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015
1	Hemorrhage 01/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2015
1	Inflammation (Inflammations) 01/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2014
1	Alzheimer Disease (Alzheimer's Disease) 10/2013
1	Knee Osteoarthritis 05/2013
1	Wounds and Injuries (Trauma) 05/2013
1	Thyroid Diseases (Thyroid Disease) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2010

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2012
7	MicroRNAs (MicroRNA)IBA 12/2019 - 01/2010
4	Activating Transcription Factor 1IBA 01/2022 - 01/2012
2	cis-trans-IsomerasesIBA 10/2013 - 05/2013
2	Messenger RNA (mRNA)IBA 05/2013 - 01/2012
1	Antiviral Agents (Antivirals)IBA 01/2024
1	Janus KinasesIBA 01/2024
1	Nucleosomes (Nucleosome)IBA 01/2024
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023
1	Mucin-1 (CA 15-3 Antigen)IBA 10/2023
1	GlypicansIBA 10/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Long Noncoding RNAIBA 01/2021
1	Medical Waste (Waste, Medical)IBA 10/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 02/2018
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 02/2018
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	pepstatin (pepstatin A)IBA 02/2018
1	bafilomycin A1IBA 02/2018
1	LipidsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Illicit Drugs (Recreational Drugs)IBA 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2017
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 12/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2016
1	Sulfonic AcidsIBA 10/2015
1	sym-trinitrobenzeneIBA 10/2015
1	baicalinIBA 10/2015
1	Cholinergic Antagonists (Anticholinergics)IBA 04/2015
1	Tiotropium Bromide (Spiriva)FDA Link 04/2015
1	T Cell Transcription Factor 1IBA 04/2015
1	SolutionsIBA 04/2015
1	AcidsIBA 01/2015
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2015
1	Huangqin-TangIBA 01/2015
1	advanced glycation end products-bovine serum albuminIBA 07/2014
1	Phosphotransferases (Kinase)IBA 03/2014
1	Checkpoint Kinase 1IBA 03/2014
1	Cyclin D1IBA 01/2014
1	ImmunosorbentsIBA 05/2013
1	EnzymesIBA 05/2013
1	OsteopontinIBA 05/2013
1	Mitogen-Activated Protein KinasesIBA 03/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2013
1	Glutathione (Reduced Glutathione)IBA 03/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Member 2 Group A Nuclear Receptor Subfamily 4IBA 01/2013
1	CytokinesIBA 01/2013
1	Orphan Nuclear ReceptorsIBA 01/2013
1	Interleukin-17 ReceptorsIBA 01/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2013
1	heparanaseIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	alcohol O-acetyltransferaseIBA 01/2012
1	X-ray Repair Cross Complementing Protein 1IBA 01/2011
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 04/2010
1	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 04/2010
1	Scavenger Receptors (Scavenger Receptor)IBA 04/2010
1	RNA (Ribonucleic Acid)IBA 01/2010
1	Homovanillic AcidIBA 08/2002
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2002
1	NAD (NADH)IBA 08/2002
1	Oxidoreductases (Dehydrogenase)IBA 08/2002

Therapy/Procedure

2	Therapeutics 01/2024 - 06/2016
2	Drug Therapy (Chemotherapy) 06/2016 - 01/2012
1	Length of Stay 10/2020
1	Hepatectomy 09/2013